American Trust’s MaxLinear MXL Stock Holding History

American Trust’s Portfolio MXL Stock Details MXL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,403	Closed	-$257K	–	494
2022 Q1	$257K	Sell	4,403 -1,261	-22%	-$76.8K	0.02%	389
2021 Q4	$427K	Buy	+5,664	New	+$363K	0.03%	181

Other funds holding MXL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

CCM

Channing Capital Management Chicago, Illinois $3.91B AUM 34.32% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

American Trust's MXL Position: Q2 2022 in Review

American Trust sold out of MaxLinear (MXL) in Q2 2022, closing a stake of 4,403 shares — an estimated $257K sold.

American Trust first reported a position in MXL in Q4 2021 and held it in 2 quarters. The position peaked at $427K in Q4 2021. 281 funds tracked by Wall St. Rank hold MXL as of Q2 2022.

American Trust reported no remaining MaxLinear position as of Q2 2022 after selling out during the quarter.
American Trust sold 4,403 MaxLinear shares in Q2 2022, an estimated $257K.
American Trust first reported a position in MaxLinear in Q4 2021 and held it in 2 quarters.
American Trust's MaxLinear position peaked at $427K in Q4 2021.
281 funds tracked by Wall St. Rank held MaxLinear as of Q2 2022.

Based on American Trust's 13F filing for Q2 2022, filed 3 Oct 2022.